U.S. Markets closed

Heron Therapeutics, Inc. (HRTX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
15.20+0.05 (+0.33%)
At close: 4:00PM EDT
People also watch
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue1,279--
Cost of Revenue35--
Gross Profit1,244--
Operating Expenses
Research Development103,12561,18354,833
Selling General and Administrative69,03435,74219,728
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-170,915-96,925-74,561
Income from Continuing Operations
Total Other Income/Expenses Net436292-919
Earnings Before Interest and Taxes-170,479-96,633-75,480
Interest Expense2,664958887
Income Before Tax-173,143-97,591-76,367
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-173,143-97,591-76,367
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-173,143-97,591-76,367
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-173,143-97,591-76,367